Donor ethics letter submitted to the Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada

Ethicists and Economists express concerns about banning compensation for plasma donors with regards to ensuring the security of a safe Immune Globulin Product Supply.

PPTA News

PPTA Responds to New York Times Article +

On February 1, The New York Times published an article that lacked balance in its portrayal of Source plasma donors. Plasma donors, including Jacqueline Watson, Kevin Hayway, and Robert Jenkins, all of whom are discussed in the article, deserve our deepest respect, gratitude, and appreciation, not negative characterizations and insinuation.
Read More
Register now for the 2019 IPPC! +

The 2019 International Plasma Protein Congress (IPPC) will be held March 19-20 at the Amsterdam Marriott Hotel in the Netherlands. Registration for the the IPPC is now open. Registration for the IPPC includes access to all general sessions, the Exhibit Hall and all IPPC breaks (you must be registered to participate in any of the IPPC activities). Individuals not registered for the IPPC will be asked to register on-site to gain access to these events.
Read More
PPTA Names Amy Efantis President & CEO +

Annapolis, MD (January 14, 2019) -- The Board of Directors of the Plasma Protein Therapeutics Association (PPTA) announced today that Amy Efantis will be its next President and Chief Executive Officer effective January 16, 2019.

Having served most recently as Vice President, Global Public Policy & Government Affairs at Biogen, Efantis joins the PPTA, the world’s leading trade association that represents more than 750 human plasma collection centers in North America and Europe as well as the manufacturers of life-saving plasma protein therapies.
Read More